amphetamine has been researched along with valproic acid in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.34) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 18 (62.07) | 29.6817 |
| 2010's | 6 (20.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Crosset, P; Klawans, HL; Patel, BC | 1 |
| Bidziński, A; Hauptmann, M; Kostowski, W; Płaźnik, A; Tamborska, E | 1 |
| Buckland, PR; McGuffin, P; Spurlock, G | 1 |
| Agmo, A; Alonso, P; Garrido, N; Medrano, A | 1 |
| Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
| Wozniak, J | 1 |
| Brody, SA; Geyer, MA; Large, CH; Ong, JC | 1 |
| Andreazza, AC; Ceresér, KM; Frey, BN; Kapczinski, F; Martins, MR; Quevedo, J; Réus, GZ; Valvassori, SS | 1 |
| Andreazza, AC; Frey, BN; Hatch, JP; Kapczinski, F; Martins, MR; Quevedo, J; Réus, GZ; Rosa, AR; Valvassori, SS | 1 |
| Amboni, G; Assis, LC; Corrêa, C; Kapczinski, F; Martins, MR; Quevedo, J; Streck, EL | 1 |
| Chen, JF; Heidmets, LT; Kalda, A; Shen, HY; Zharkovsky, A | 1 |
| Andreazza, AC; Cacilhas, AA; Ceresér, KM; Frey, BN; Kapczinski, F; Quevedo, J; Valvassori, SS; Walz, JC | 1 |
| Kim, JH; Kim, S; Kim, WY | 1 |
| Amboni, G; Di-Pietro, PB; Kapczinski, F; Luz, G; Quevedo, J; Rezin, GT; Scaini, G; Streck, EL; Valvassori, SS | 1 |
| Chen, G; Creson, TK; Engel, SR; Hao, Y; Landreth, GE; Maeng, S; Manji, HK; Nekrasova, T; Shen, Y | 1 |
| Chen, JF; Ferrara, J; Kalda, A; Shen, HY; Yu, L; Zhu, J | 1 |
| Andreazza, AC; Frey, BN; Giasson, K; Gonçalves, CA; Kapczinski, F; Kauer-Sant'Anna, M; Quevedo, J; Réus, GZ; Ribeiro, L; Salvador, M; Stertz, L; Valvassori, SS; Zanotto, C | 1 |
| Ferreira, CL; Matté, C; Mattos, C; Quevedo, J; Rezin, GT; Scherer, EB; Streck, EL; Valvassori, SS; Wyse, AT; Zugno, AI | 1 |
| Adedoyin, A; Beyer, CE; Cai, Z; Comery, TA; Dwyer, JM; Kelly, MP; Liu, Z; Logue, SF; Majchrowski, H; Rosenzweig-Lipson, S | 1 |
| Agam, G; Almog, O; Belmaker, RH; Bersudsky, Y; Heldman, E; Ishikawa, Y; Mann, L; Vatner, SF | 1 |
| Douma, TN; Groenink, L; Kolarz, A; Olivier, B; Postma, Y | 1 |
| Benfante, R; Bolognesi, E; Braida, D; Chiappedi, M; Clerici, M; Corradini, I; De Astis, S; Fornasari, D; Ghezzo, A; Guerini, FR; Matteoli, M; Pattini, L; Ponzoni, L; Sala, M | 1 |
| Tremblay, M; Winstanley, CA | 1 |
2 review(s) available for amphetamine and valproic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recognizing and managing bipolar disorder in children.
Topics: Adolescent; Age Factors; Amphetamine; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Child, Preschool; Comorbidity; Humans; Lithium; Mental Disorders; Treatment Outcome; Valproic Acid | 2005 |
27 other study(ies) available for amphetamine and valproic acid
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Failure of increased brain gamma-aminobutyric acid levels to influence amphetamine-induced stereotyped behavior.
Topics: Aminobutyrates; Amphetamine; Animals; Behavior; Brain; Brain Chemistry; Drug Interactions; gamma-Aminobutyric Acid; Guinea Pigs; Humans; Male; Stereotyped Behavior; Valproic Acid | 1975 |
Brain neurotransmitter systems mediating behavioral deficits produced by inescapable shock treatment in rats.
Topics: Alanine; Amphetamine; Animals; Antidepressive Agents; Atropine; Brain; Desipramine; Diazepam; Electroshock; Escape Reaction; Male; Motor Activity; Neurotransmitter Agents; Physostigmine; Rats; Rats, Inbred Strains; Valproic Acid | 1988 |
Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels.
Topics: Amphetamine; Animals; Anticonvulsants; Aromatic-L-Amino-Acid Decarboxylases; Base Sequence; Brain; Enzyme Inhibitors; gamma-Aminobutyric Acid; Gene Expression Regulation, Enzymologic; Male; Molecular Sequence Data; Oligonucleotide Probes; Organ Specificity; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Transcription, Genetic; Valproic Acid; Vigabatrin | 1996 |
GABAergic drugs inhibit amphetamine-induced distractibility in the rat.
Topics: 4-Aminobutyrate Transaminase; Amphetamine; Animals; Attention; Baclofen; Central Nervous System Stimulants; Enzyme Inhibitors; GABA Agents; GABA Agonists; Male; Motor Activity; Rats; Rats, Wistar; Valproic Acid | 1997 |
Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Topics: Amphetamine; Animals; Anthracenes; Antimanic Agents; Blotting, Western; Carbamazepine; Cell Line; Cell Survival; Chloramphenicol O-Acetyltransferase; Corticosterone; Dose-Response Relationship, Drug; Flavonoids; Gene Expression Regulation, Enzymologic; Imidazoles; Indoles; Inositol; Lithium; Maleimides; Protein Kinase C; Protein Kinase C-alpha; Pyridines; Receptors, Glucocorticoid; Tamoxifen; Tetradecanoylphorbol Acetate; Valproic Acid | 2004 |
An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition.
Topics: Amphetamine; Anesthetics, Dissociative; Animals; Antimanic Agents; Carbamazepine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Ketamine; Lithium; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Phenytoin; Reflex, Startle; Valproic Acid | 2005 |
Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania.
Topics: Affect; Amphetamine; Animals; Antimanic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hippocampus; Lithium; Male; Rats; Rats, Wistar; Valproic Acid | 2006 |
Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Bipolar Disorder; Central Nervous System Stimulants; Hippocampus; Lithium; Male; Motor Activity; Nerve Growth Factors; Rats; Rats, Wistar; Valproic Acid | 2006 |
Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
Topics: Amphetamine; Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Citrate (si)-Synthase; Disease Models, Animal; Drug Interactions; Hippocampus; Lithium Chloride; Male; Rats; Rats, Wistar; Valproic Acid | 2007 |
Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice.
Topics: Amphetamine; Animals; Association Learning; Behavior, Animal; Butyric Acid; Central Nervous System Stimulants; Drug Interactions; Environment; Enzyme Inhibitors; Histones; Male; Mice; Mice, Inbred C57BL; Motor Activity; Time Factors; Valproic Acid | 2007 |
Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Bipolar Disorder; Disease Models, Animal; Hippocampus; Lithium Compounds; Male; Neurotrophin 3; Rats; Rats, Wistar; Sodium Chloride; Valproic Acid | 2008 |
Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity.
Topics: Amphetamine; Animals; Anticonvulsants; Central Nervous System Stimulants; Disease Models, Animal; Drug Interactions; Hyperkinesis; Male; Microinjections; Motor Activity; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Valproic Acid | 2008 |
Brain creatine kinase activity in an animal model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Bipolar Disorder; Brain; Central Nervous System Stimulants; Creatine Kinase; Disease Models, Animal; Drug Therapy, Combination; Injections, Intraperitoneal; Lithium Compounds; Male; Motor Activity; Rats; Rats, Wistar; Valproic Acid | 2008 |
The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.
Topics: Adjuvants, Immunologic; Administration, Oral; Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Central Nervous System Stimulants; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Lithium Chloride; Locomotion; Maze Learning; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Olanzapine; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Swimming; Valproic Acid | 2009 |
Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Topics: Acetylation; Amphetamine; Animals; Butyric Acid; Central Nervous System Stimulants; Chromatin Immunoprecipitation; Corpus Striatum; CREB-Binding Protein; Drug Interactions; Enzyme Inhibitors; Gene Expression; Histones; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phosphorylation; Proto-Oncogene Proteins c-fos; Time Factors; Valproic Acid | 2008 |
Effects of mood stabilizers on DNA damage in an animal model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Antioxidants; Bipolar Disorder; Central Nervous System Stimulants; Comet Assay; DNA Damage; Hippocampus; Lipid Peroxidation; Lithium Chloride; Male; Micronucleus Tests; Motor Activity; Oxidative Stress; Rats; Rats, Wistar; Valproic Acid | 2008 |
Na+,K+-ATPase activity in an animal model of mania.
Topics: Amphetamine; Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Disease Models, Animal; Hippocampus; Lithium Compounds; Male; Motor Activity; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Valproic Acid | 2009 |
The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizers.
Topics: Affect; Amphetamine; Animals; Antimanic Agents; Anxiety; Bipolar Disorder; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Male; Mice; Mice, Inbred C57BL; Models, Neurological; Motor Activity; Valproic Acid | 2009 |
Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
Topics: Adenylyl Cyclases; Amphetamine; Analysis of Variance; Animals; Antimanic Agents; Benzazepines; Carbamazepine; Chlorocebus aethiops; Colforsin; COS Cells; Cyclic AMP; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Isoenzymes; Lithium; Mice; Mice, Knockout; Models, Molecular; Motor Activity; Rotarod Performance Test; Swimming; Transfection; Valproic Acid | 2009 |
The amphetamine-chlordiazepoxide mixture, a pharmacological screen for mood stabilizers, does not enhance amphetamine-induced disruption of prepulse inhibition.
Topics: Acoustic Stimulation; Affect; Amphetamine; Analysis of Variance; Animals; Anticonvulsants; Antimanic Agents; Behavior, Animal; Chlordiazepoxide; Drug Evaluation, Preclinical; Drug Synergism; Hyperkinesis; Inhibition, Psychological; Male; Mice; Mice, Inbred C57BL; Motor Activity; Piperazines; Reflex, Startle; Valproic Acid | 2011 |
Association between SNAP-25 gene polymorphisms and cognition in autism: functional consequences and potential therapeutic strategies.
Topics: Adolescent; Amphetamine; Animals; Autistic Disorder; Behavior, Animal; Central Nervous System Stimulants; Child; Cognition; Electroencephalography; Enzyme Inhibitors; Female; Heterozygote; Hippocampus; Humans; Male; Mice; Motor Activity; Prefrontal Cortex; Recognition, Psychology; Social Behavior; Synaptosomal-Associated Protein 25; Valproic Acid | 2015 |
Anticonvulsant medications attenuate amphetamine-induced deficits in behavioral inhibition but not decision making under risk on a rat gambling task.
Topics: Amphetamine; Animals; Anticonvulsants; Carbamazepine; Central Nervous System Stimulants; Choice Behavior; Decision Making; Gambling; Male; Rats, Long-Evans; Reinforcement Schedule; Reward; Risk; Valproic Acid | 2016 |